Abstract:Murine H22 hepatocarcinoma model is so popular to be used for the preclinical anticancer candidate’s evaluation. However, the metabolic biomarkers of this model were not identified. Meanwhile, Rhizoma Paridis saponins (RPS) as natural products have been found to show strong antitumor activity, while its anti-cancer mechanism is not clear. To search for potential metabolite biomarkers of this model, serum metabonomics approach was applied to detect the variation of metabolite biomarkers and the related metabolism genes and signaling pathway were used to deduce the antitumor mechanisms of RPS. As a result, ten serum metabolites were identified in twenty-four mice including healthy mice, non-treated cancer mice, RPS-treated cancer mice and RPS-treated healthy mice. RPS significantly decreased tumor weight correlates to down-regulating lactate, acetate, N-acetyl amino acid and glutamine signals (p < 0.05), which were marked metabolites screened according to the very important person (VIP), loading plot and receiver operating characteristic curve (ROC) tests. For the analysis of metabolic enzyme related genes, RPS reversed the aerobic glycolysis through activating tumor suppressor p53 and PTEN, and suppressed FASN to inhibit lipogenesis. What’s more, RPS repressed Myc and GLS expression and decreased glutamine level. The regulating PI3K/Akt/mTOR and HIF-1α/Myc/Ras networks also participated in these metabolic changes. Taken together, RPS suppressed ATP product made the tumor growth slow, which indicated a good anti-cancer effect and new angle for understanding the mechanism of RPS. In conclusion, this study demonstrated that the utility of 1H NMR metabolic profiles taken together with tumor weight and viscera index was a promising screening tool for evaluating the antitumor effect of candidates. In addition, RPS was a potent anticancer agent through inhibiting cancer cellular metabolism to suppress proliferation in hepatoma H22 tumor murine, which promoted the application of RPS in the future.

Combination Therapy of Cyclophosphamide and Rhizoma Paridis Saponins on Anti-Hepatocarcinoma Mice and Effects on Cytochrome P450 Enzyme Expression

Antitumor Pathway of Rhizoma Paridis Saponins Based on the Metabolic Regulatory Network Alterations in H22 Hepatocarcinoma Mice.

Effects of Pennogenin 3-O-<i>β</i>-Chacotrioside, a Steroidal Saponin from <i>Rhizoma paridis</i>, on Proliferation Inhibition and Apoptosis Induction in Non-Small Cell Lung Cancer Cells

Antitumor and antimetastatic activities of Rhizoma Paridis saponins.

A Synergistic Antitumor Effect of Polyphyllin I and Formosanin C on Hepatocarcinoma Cells.

Global Metabolic Profiling for the Study of Rhizoma Paridis Saponins‐induced Hepatotoxicity in Rats

Antitumor and anti-metastatic mechanisms of Rhizoma paridis saponins in Lewis mice.

Turmeric Enhancing Anti-Tumor Effect of Rhizoma Paridis Saponins by Influencing Their Metabolic Profiling in Tumors of H22 Hepatocarcinoma Mice

Metabolic regulatory network alterations reveal different therapeutic effects of cisplatin and Rhizoma paridis saponins in Lewis pulmonary adenoma mice

Inhibition of urethane-induced lung carcinogenesis in mice by a Rhizoma paridis saponin involved EGFR/PI3K/Akt pathway

Inhibition of Diethylnitrosamine-Induced Liver Cancer in Rats by Rhizoma Paridis Saponin.

Paridis Saponins Inhibiting Carcinoma Growth and Metastasis in Vitro and in Vivo

Combinatorial treatment of Rhizoma Paridis saponins and sorafenib overcomes the intolerance of sorafenib

Growth Inhibition by Pennogenyl Saponins from Rhizoma Paridis on Hepatoma Xenografts in Nude Mice

Inhibition of lung cancer in diethylnitrosamine-induced mice by Rhizoma paridis saponins.

The role of Rhizoma Paridis saponins on anti-cancer: The potential mechanism and molecular targets

Curcuma increasing antitumor effect of Rhizoma paridis saponins through absorptive enhancement of paridis saponins.

Utilization of metabonomics to identify serum biomarkers in murine H22 hepatocarcinoma and deduce antitumor mechanism of Rhizoma Paridis saponins

Rhizoma Paridis Saponins Induces Cell Cycle Arrest and Apoptosis in Non-Small Cell Lung Carcinoma A549 Cells

Curcumin Alleviated the Toxic Reaction of Rhizoma Paridis Saponins in a 45-Day Subchronic Toxicological Assessment of Rats.

Proteomic Analysis of Anti-Tumor Effects by Rhizoma Paridis Total Saponin Treatment in HepG2 Cells.